Sort   by:  
 Page size 
UnknownA Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis.
Not available
S-EPMC8069820 | biostudies-literature
UnknownAnti-SARS-CoV-2 Antibody Responses in Convalescent Plasma Donors Are Increased in Hospitalized Patients; Subanalyses of a Phase 2 Clinical Study.
Not available
S-EPMC7760522 | biostudies-literature
UnknownEnhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.
Not available
S-EPMC3165762 | biostudies-literature
UnknownComparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost.
Not available
S-EPMC4474309 | biostudies-literature
Sort   by:  
 Page size